pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-181a-1 |
Genomic Coordinates | chr1: 198859044 - 198859153 |
Synonyms | MIR213, MIRN181A1, MIRN213, mir-213, MIR181A1 |
Description | Homo sapiens miR-181a-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-181a-2 |
Genomic Coordinates | chr9: 124692442 - 124692551 |
Synonyms | MIRN181A, MIRN181A2, MIR181A2, MIR181A2HG |
Description | Homo sapiens miR-181a-2 stem-loop |
Comment | This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-181a-5p | |||||||||||||||||||||||||||||||||||||||||||||||||
Sequence | 24| AACAUUCAACGCUGUCGGUGAGU |46 | |||||||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CDX2 | ||||||||||||||||||||
Synonyms | CDX-3, CDX2/AS, CDX3 | ||||||||||||||||||||
Description | caudal type homeobox 2 | ||||||||||||||||||||
Transcript | NM_001265 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CDX2 | |||||||||||||||||||||
3'UTR of CDX2 (miRNA target sites are highlighted) |
>CDX2|NM_001265|3'UTR 1 CCCACCGGGTTCTGCAGCGGCAGAGCAATTCCAGGCTGAGCCATGAGGAGCGTGGACTCTGCTAGACTCCTCAGGAGAGA 81 CCCCTCCCCTCCCACCCACAGCCATAGACCTACAGACCTGGCTCTCAGAGGAAAAATGGGAGCCAGGAGTAAGACAAGTG 161 GGATTTGGGGCCTCAAGAAATATACTCTCCCAGATTTTTACTTTTTCCCATCTGGCTTTTTCTGCCACTGAGGAGACAGA 241 AAGCCTCCGCTGGGCTTCATTCCGGACTGGCAGAAGCATTGCCTGGACTGACCACACCAACCAGGCCTTCATCCTCCTCC 321 CCAGCTCTTCTCTTCCTAGATCTGCAGGCTGCACCTCTGGCTAGAGCCGAGGGGAGAGAGGGACTCAAGGGAAAGGCAAG 401 CTTGAGGCCAAGATGGCTGCTGCCTGCTCATGGCCCTCGGAGGTCCAGCTGGGCCTCCTGCCTCCGGGCAGGCAAGGTTT 481 ACACTGCGGAAGCCAAAGGCAGCTAAGATAGAAAGCTGGACTGACCAAAGACTGCAGAACCCCCAGGTGGCCTGCGTCTT 561 TTTTCTCTTCCCTTCCCAGACCAGGAAAGGCTTGGCTGGTGTATGCACAGGGTGTGGTATGAGGGGGTGGTTATTGGACT 641 CCAGGCCTGACCAGGGGGCCCGAACAGGGACTTGTTTAGAGAGCCTGTCACCAGAGCTTCTCTGGGCTGAATGTATGTCA 721 GTGCTATAAATGCCAGAGCCAACCTGGACTTCCTGTCATTTTCACAATCTTGGGGCTGATGAAGAAGGGGGTGGGGGGAG 801 TTTGTGTTGTTGTTGCTGCTGTTTGGGTTGTTGGTCTGTGTAACATCCAAGCCAGAGTTTTTAAAGCCTTCTGGATCCAT 881 GGGGGGAGAAGTGATATGGTGAAGGGAAGTGGGGAGTATTTGAACACAGTTGAATTTTTTCTAAAAAGAAAAAGAGATAA 961 ATGAGCTTTCCAGATTTCAGATTCTGTATTTATCTTCAGATTTTGTCTGCAACTATTTTTTATTTTTTAAAGAAATGAAA 1041 TATCTTCAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Article |
- Ji J; Yamashita T; Budhu A; Forgues M; Jia et al. - Hepatology (Baltimore, Md.), 2009
MicroRNAs (miRNAs) are endogenous small noncoding RNAs that regulate gene expression with functional links to tumorigenesis. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and it is heterogeneous in clinical outcomes and biological activities. Recently, we have identified a subset of highly invasive epithelial cell adhesion molecule (EpCAM)(+) HCC cells from alpha-fetoprotein (AFP)(+) tumors with cancer stem/progenitor cell features, that is, the abilities to self-renew, differentiate, and initiate aggressive tumors in vivo. Here, using a global microarray-based miRNA profiling approach followed by validation with quantitative reverse transcription polymerase chain reaction, we have demonstrated that conserved miR-181 family members were up-regulated in EpCAM(+)AFP(+) HCCs and in EpCAM(+) HCC cells isolated from AFP(+) tumors. Moreover, miR-181 family members were highly expressed in embryonic livers and in isolated hepatic stem cells. Importantly, inhibition of miR-181 led to a reduction in EpCAM(+) HCC cell quantity and tumor initiating ability, whereas exogenous miR-181 expression in HCC cells resulted in an enrichment of EpCAM(+) HCC cells. We have found that miR-181 could directly target hepatic transcriptional regulators of differentiation (for example, caudal type homeobox transcription factor 2 [CDX2] and GATA binding protein 6 [GATA6]) and an inhibitor of Wnt/beta-catenin signaling (nemo-like kinase [NLK]). Taken together, our results define a novel regulatory link between miR-181s and human EpCAM(+) liver cancer stem/progenitor cells and imply that molecular targeting of miR-181 may eradicate HCC.
LinkOut: [PMID: 19585654]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
551 hsa-miR-181a-5p Target Genes:
Functional analysis: